Impel Pharmaceuticals
Scott Patry is an accomplished Senior District Business Manager at Bristol Myers Squibb, where responsibilities include building and leading a new Neuro Psych team for the launch of a schizophrenia product in the Virginias. Previous experience includes serving as a Regional Sales Manager at Impel Pharmaceuticals, where Scott led a team for a new migraine drug launch, and holding various roles at Amarin Corporation, including Director of Trade and Area Sales Director, contributing significantly to sales growth and strategic initiatives. Scott has also worked as an Executive Recruiter in the pharmaceutical and biotech sectors, and held regional leadership positions at companies such as Publicis Touchpoint Solutions, Health Diagnostic Laboratory, Auxilium Pharmaceuticals, and Sunovion Pharmaceuticals, demonstrating a strong track record in sales management, team building, and market launch strategies. Scott holds a BA in Political Science from Loyola University Maryland.
This person is not in any offices
Impel Pharmaceuticals
Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.